STATEMENT OF PURPOSE
RS30657 / H0370
This legislation would provide for a tightly regulated system for medical cannabis. Patients diagnosed with
a substantial health condition such as cancer, ALS, AIDS, wasting syndrome, Crohn’s disease, epilepsy,
debilitating seizures, and terminal illness, would be eligible for a medical cannabis card. Medical cannabis
cards would be valid for up to a maximum of one year, upon which a renewal must be sought.
“Medical cannabis” is defined as an “ingestible cannabis processed to a tablet, chewable, droplet, or pill
containing up to ten (10) milligrams of tetrahydrocannabinol,” and does not include any type of raw, smoked
or vaped form. A cardholder must obtain medical cannabis from an Idaho licensed pharmacist.
Producers of medical cannabis would have to obtain a production license in Idaho to grow and handle medical
cannabis and be strictly regulated including the submission of an operating plan, inspections, testing of product
and criminal background checks.
FISCAL NOTE
This legislation does not have an impact on the State’s General Fund because fees will cover the administration
of the program. There will be no impact on any dedicated fund or federal fund by removing or rescheduling
products to the Controlled Substances Act.
Contact:
Jeremy Chou
Givens Pursley
(208) 388-1200
DISCLAIMER: This statement of purpose and fiscal note are a mere attachment to this bill and prepared by a proponent
of the bill. It is neither intended as an expression of legislative intent nor intended for any use outside of the legislative
process, including judicial review (Joint Rule 18).
Statement of Purpose / Fiscal Note Bill SOP/FN INTRODUCED: 03/24/2023, 8:17 AM


Statutes affected:
Bill Text: 37-2705, 37-2707, 37-2732, 37-2732B